Notice of Award to Meridian Bioscience

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on July 14, 2026.

Award Information

DEPT OF DEFENSE awarded this contract to for $150,741 on July 14, 2026, as part of federal procurement initiatives.

This award is part of federal acquisition procurement activities.

Award Number
W81K0026PA157
Award Amount
$150,741
Award Date
July 14, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in JBSA FT SAM HOUSTON, TX
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
W81K00-26-P-A157
Opportunity Type
Award Notice
Sub-Agency
DEPT OF THE ARMY
Office
W40M MRC0 WEST
Posted Date
Tuesday, July 14, 2026
Response Deadline
Not specified
PSC Code
6550
Set-Aside
No Set Aside
Status
Active

Description

The Medical Readiness Contracting Office West (MRCO-W), Fort Hood Health Contracting Branch, Fort Hood, Texas did award a Firm Fixed-Price, sole source contract to Meridian Bioscience Inc, under authority of RFO Federal Acquisition Regulation (FAR) 12.102(a) for purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization for analyzer lease, supply of testing reagents, and associated testing hardware for the detection of Helicobacter pylori and Clostridioides difficile to support Carl R. Darnall Army Medical Center (CRDAMC), Fort Hood, Texas, 76544. The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostic Substance Manufacturing. The Small Busine

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in JBSA FT SAM HOUSTON, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.